Arc launches virtual cell AI challenge
Genetic Engineering & Biotechnology News (GEN) - 26-Jun-2025AI contest to boost virtual cells for gene and disease prediction
Fay Lin
Senior Editor at GEN Biotechnology
Fay Lin is a computational biologist turned science journalist and editor. She is passionate about exploring the impact of artificial intelligence (AI) on the biotech industry, including its applications in drug discovery, precision medicine, sustainability, and beyond.
Visit website: https://www.genengnews.com/author-archive/?author-id=24485
See also
Genetic Engineering & Biotechnology News (GEN)
News provider in the fields of biotechnology and genetic engineering
Details last updated 23-Jan-2025
Articles written by Fay Lin
Basecamp reveals million-species protein dataset
Genetic Engineering & Biotechnology News (GEN) - 11-Jun-2025Vast new dataset could supercharge AI-driven protein and drug design across biology and medicine
Boltz‑2: open‑source AI brings binding affinity modelling into every lab
Genetic Engineering & Biotechnology News (GEN) - 06-Jun-2025Fast, free MIT AI predicts molecular binding strength in seconds—no license needed
Evo 2: the AI model redesigning life’s genetic code
Genetic Engineering & Biotechnology News (GEN) - 19-Feb-2025Arc Institute’s AI expands genetic design to complex life, advancing biotech and medicine
Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy
Genetic Engineering & Biotechnology News (GEN) - 15-Jan-2025A partnership advancing synthetic AAV vectors to tackle gene therapy challenges
